Diurnal is now Neurocrine UK

Information for UK Patients on Alkindi®

UK laws and regulations limit the amount of product information that we can provide to the public on our website, the information here is intended for patients treated with Alkindi and their carers.

Alkindi Patient Information

This page is specifically intended to support UK patients who have been prescribed Alkindi by their doctor. If you have any questions about your medication, ask your doctor, nurse or pharmacist and read the Patient Information Leaflet (PIL) provided with your medicine and which is reproduced here. Click here to see the Alkindi Patient Information Leaflet

Alkindi - Administration video

This video is intended for patients who have been prescribed Alkindi and provides a step-by-step administration guide.

Adverse events should be reported. Reporting Forms and information can be found at www.mhra.gov.uk/yellowcard

Adverse Events should also be reported to Neurocrine on adverseeventsEU@neurocine.com

Patient Groups

For more information and support visit these useful sites:

Neurocrine Group Ltd (Company Number: 09846650) and its subsidiary, Neurocrine UK Ltd (Company Number: 05237326) are companies registered in England and Wales. Registered Offices: Cardiff Medicentre, Heath Park, Cardiff, CF14 4UJ, UK.